Wellington Management Group’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.89M Buy
94,012
+9,312
+11% +$187K ﹤0.01% 1585
2025
Q1
$1.67M Buy
84,700
+3,784
+5% +$74.5K ﹤0.01% 1593
2024
Q4
$1.82M Buy
80,916
+10,746
+15% +$242K ﹤0.01% 1577
2024
Q3
$1.79M Buy
70,170
+36,267
+107% +$926K ﹤0.01% 1557
2024
Q2
$792K Buy
+33,903
New +$792K ﹤0.01% 1711